147.2401.76% ( -2.640 )
Closed: Oct 22, 16:00:00 (EDT)Current ValuationThe current P/E ratio is 114.49, within the reasonable range, cheaper than 22.58% of the time in the past 3 years, and the industry ranks 57/256, the industry Median -1.13.
114.49xP/E
$147.24Stock price
$1.29Earnings per share
114.49xP/E
Stock price$147.24Earnings per share$1.29
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 20.94x
- Typical range
- 12.91x–117.34x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0295887116
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
MRKUSMerck | 114.49x | 81.16% | $363.27B |
CORTUSCorcept Therap | 214.13x | 148.29% | $11.62B |
HCMUSHutchmed China | 139.31x | 90.18% | $2.49B |
ETONUSEton Pharmaceuticals | 112.68x | 739.71% | $1.43B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
